Trans GERD: efficacy and tolerability of esomeprazol in patients under ordinary medical care conditions
Study identifier:1312004011
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Trans GERD: efficacy and tolerability of esomeprazol in patients under ordinary medical care conditions
Medical condition
gastrointestinal diseases
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
29586
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Jan 2006
Primary Completion Date: 01 Mar 2006
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 patients with gastrointestinal disorders and patients with acid associated gastrointestinal symptoms treated with esomeprazole. | - |
Contacts
Investigators
Principal Investigator
Kai Richter
Medical Department AstraZeneca Germany
